|This Slide: #34 of 49|
Slide #34. American Capital, Ltd. — Cambridge Major Laboratories, Inc.
American Capital, Ltd. (ACAS)
Cambridge Major Laboratories, Inc.
American Capital, Ltd. announced today that it has committed $212 million in the One Stop Buyout of Cambridge Major Laboratories, Inc. ("CML" or the "Company"), a leading global provider of complex chemistry-based outsourcing services to the pharmaceutical and biotechnology industries. CML expands American Capital's portfolio of healthcare products and services companies, which have aggregate revenues of over $600 million1. American Capital's investment took the form of debt and preferred and common equity. Jefferies & Company, Inc., served as sole financial advisor to CML on the transaction. CML was a portfolio company of Arlington Capital Partners prior to American Capital's investment.
American Capital is a global asset manager and private equity firm. Co., both directly and through its asset management business, originates, underwrites and manages investments in middle market private equity, leveraged finance, real estate, energy and structured products. Co. primarily invests in senior and mezzanine debt and equity in buyouts of private companies sponsored by Co. or sponsored by other private equity funds and provides capital directly to private and small public companies. As of Dec 31 2015, Co. had $73.34 billion of total assets under management, including total assets of the funds under management by its portfolio company, American Capital Asset Management, LLC.
Open the ACAS Page at The Online Investor »
Hold (2.00 out of 4)
(ranked higher than approx. 100% of all stocks covered)
Based on Zacks ABR data;
powered by Xignite